Alexion Pharmaceuticals names new CFO By: MarketMinute.com Stock News June 14, 2017 at 17:55 PM EDT Alexion Pharmaceuticals Inc. (Nasdaq: ALXN) named Paul Clancy to the position of chief financial officer. Shares of the biopharmaceutical soared $10.00 to close at $118.00. Related Stocks: Alexion Pharmaceuticals